Dabigatran 150mg
Generic For: Pradaxa
Dabigatran 150mg, sold under the brand name Pradaxa, is an oral anticoagulant (blood thinner) that works by directly inhibiting thrombin. It is FDA-approved to reduce the risk of stroke in people with nonvalvular atrial fibrillation and to treat and prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). After a licensed provider reviews your prescription, your medication ships from a licensed U.S. pharmacy.
Select Quantity *
60-day supply · $1.58/capsule
How It Works
- Select your medication
- Licensed providers review & prescribe
- Our licensed U.S. pharmacists fill your prescription
- Delivered to you as soon as the next day
Price: $95.00
HSA/FSA Eligible*Doctor visit fee & delivery cost not included in price. Refills at provider discretion.
Pharmacist Support
Fast Shipping
Licensed U.S. Pharmacy
Buy Dabigatran 150mg (Pradaxa) Online
A direct thrombin inhibitor anticoagulant for stroke prevention in atrial fibrillation and treatment of DVT and pulmonary embolism
Dabigatran 150mg Quick Facts
| Drug class | Direct thrombin inhibitor anticoagulant |
|---|---|
| Treats | Stroke prevention in atrial fibrillation, DVT, pulmonary embolism |
| Form | Capsule |
| Typical dosing | Take 1 capsule by mouth twice a day. |
| Prescription required | Yes — prescription only |
What Is Dabigatran 150mg?
Dabigatran (brand name Pradaxa) is a prescription anticoagulant in the direct thrombin inhibitor class. It reduces the blood's ability to form clots by blocking thrombin, an enzyme central to the clotting process. Unlike warfarin, dabigatran does not require routine blood-level monitoring or dietary vitamin K restrictions. It is taken as an oral capsule, typically twice daily, and is used to lower the risk of stroke and to treat or prevent dangerous blood clots.
What Does Dabigatran 150mg Treat?
Stroke and systemic embolism risk reduction in nonvalvular atrial fibrillation
Treatment of deep vein thrombosis (DVT) after initial parenteral anticoagulation
Treatment of pulmonary embolism (PE) after initial parenteral anticoagulation
Reducing the risk of recurrent DVT and PE
Prophylaxis of DVT and PE following hip replacement surgery
Dabigatran 150mg Dosage
Nonvalvular atrial fibrillation: 150 mg by mouth twice daily (CrCl >30 mL/min).
DVT/PE treatment: 150 mg by mouth twice daily after 5–10 days of parenteral anticoagulation.
Recurrent DVT/PE risk reduction: 150 mg by mouth twice daily.
Your prescriber will determine the dose and duration that are right for you. Always follow the directions on your prescription label.
Dabigatran 150mg Side Effects
Common side effects
- Indigestion or upset stomach (dyspepsia)
- Stomach pain
- Nausea
- Heartburn
- Diarrhea
- Minor bruising
- Minor bleeding (e.g., nosebleeds, gum bleeding)
Serious side effects
Stop taking this medication and seek medical attention right away if you experience:
- Major or uncontrolled bleeding
- Blood in urine or stool (black, tarry stools)
- Coughing up or vomiting blood
- Severe allergic reaction (swelling of face, tongue, or throat; difficulty breathing)
- Spinal or epidural hematoma after spinal procedures (numbness, weakness, loss of bladder/bowel control)
- Unexplained severe headache, dizziness, or weakness
Warnings & Interactions
Do not stop taking without talking to your provider; premature discontinuation increases the risk of stroke and clots
Risk of spinal or epidural hematoma with spinal anesthesia or spinal puncture
Contraindicated with active pathological bleeding
Contraindicated in patients with mechanical prosthetic heart valves
Avoid use with P-gp inducers such as rifampin
Use caution with P-gp inhibitors in patients with reduced kidney function
Increased bleeding risk when combined with aspirin, NSAIDs, or other anticoagulants
Tell your prescriber about all medications, supplements, and health conditions before starting dabigatran 150mg.
Talk to U.S.-Based Support
Our licensed pharmacy team in Boca Raton, Florida — real people, no overseas call centers.